Suppr超能文献

[选择性激光小梁成形术(SLT)作为正常眼压性青光眼初始治疗的结果]

[Results of selective laser trabeculoplasty (SLT) as initial treatment for normal tension glaucoma].

作者信息

Nitta Koji, Sugiyama Kazuhisa, Mawatari Yoshiro, Tanahashi Toshiro

机构信息

Department of Ophthalmology, Fukui-ken Saiseikai Hospital, 7-1 Funabashi, Wadanaka-machi, Fukui-shi 918-8503, Japan.

出版信息

Nippon Ganka Gakkai Zasshi. 2013 Apr;117(4):335-43.

Abstract

PURPOSE

A 3-year prospective study was performed to evaluate treatment outcomes following selective laser trabeculoplasty (SLT) used as initial treatment for normal tension glaucoma (NTG).

SUBJECTS AND METHODS

SLT was performed as initial treatment in 42 NTG patients (42 eyes). Thirty-seven of the patients were untreated and 5 patients had discontinued antiglaucoma medications. Two patients were excluded because they did not visit our clinic during the study period. The study was conducted on the remaining subjects (40 eyes of 40 patients).

RESULTS

The intraocular pressure (IOP) was 15.8 +/- 1.8 mmHg before SLT, 13.2 1.9 mmHg after one year, 13.5 +/- 1.9 mmHg after two years, and 13.5 +/- 1.9 mmHg after three years. The IOP after SLT was significantly lower than that before SLT. One month after SLT, the outflow pressure was improved at least 20% (deltaOP) in 92.5% of the patients. The success rate for the effect of IOP reduction at three years after SLT was 40.0% by Kaplan-Meier survival analysis. 27.5% of the patients who had two consecutive deltaOP less than 20%, 25.0% of the patients who had begun antiglaucoma ophthalmic solution, and 15.0% of the patients who had undergone repeated SLT were judged to have reached the endpoint. Kaplan-Meier survival analysis revealed that the success rate for the visual field at three years after SLT was 82.4% (the visual field loss progression was judged to have reached its endpoint when a significant sensitivity loss was first detected in two consecutive points of the same adjacent test points of at least 3 points in the Glaucoma Progressive Analysis for the Humphrey Visual Field Analyzer). Complications included conjunctival hyperemia (52.5%), eye discomfort (12.5%), visual disturbance (blurry vision and photophobia) (10.0%), and eye pain (5.0%). These complications resolved within a few days, and there were no severe complications such as increased IOP or iritis.

CONCLUSION

Our results suggest that SLT is an effective initial treatment for NTG.

摘要

目的

进行一项为期3年的前瞻性研究,以评估选择性激光小梁成形术(SLT)作为正常眼压性青光眼(NTG)初始治疗后的治疗效果。

对象与方法

对42例NTG患者(42只眼)进行SLT作为初始治疗。其中37例患者未接受过治疗,5例患者已停用抗青光眼药物。2例患者因在研究期间未到我院就诊而被排除。研究在其余受试者(40例患者的40只眼)中进行。

结果

SLT术前眼压(IOP)为15.8±1.8 mmHg,术后1年为13.2±1.9 mmHg,术后2年为13.5±1.9 mmHg,术后3年为13.5±1.9 mmHg。SLT术后眼压显著低于术前。SLT术后1个月,92.5%的患者房水流出阻力改善至少20%(ΔOP)。通过Kaplan-Meier生存分析,SLT术后3年眼压降低效果的成功率为40.0%。连续两次ΔOP小于20%的患者中有27.5%,开始使用抗青光眼眼药水的患者中有25.0%,以及接受重复SLT的患者中有15.0%被判定达到终点。Kaplan-Meier生存分析显示,SLT术后3年视野成功率为82.4%(当在Humphrey视野分析仪的青光眼进展分析中,在至少3个点的同一相邻测试点的连续两个点首次检测到显著的敏感度损失时,视野损失进展被判定达到终点)。并发症包括结膜充血(52.5%)、眼部不适(12.5%)、视觉障碍(视力模糊和畏光)(10.0%)和眼痛(5.0%)。这些并发症在数天内消退,未出现眼压升高或虹膜炎等严重并发症。

结论

我们的结果表明,SLT是NTG有效的初始治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验